GCs are the most widely used anti-inflammatory drugs and obesity, one of the major adverse effects of GCs, is thought to be caused by aberrant activation of orexigenic GR targets10. Here, NR3C1 is linked to obesity due to melanocortin 4 receptor deficiency.